Trial
NCT01772719
Overcoming Chemotherapy Resistance In Refractory Multiple Myeloma With Simvastatin and Zoledronic Acid
UnknownTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Louisville
Collaborators
James Graham Brown Cancer Center
Condition
Multiple Myeloma
Intervention
Simvastatin and zoledronic acid
Why stopped
Principal Investigator left institution-study not continued
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-11-18